CODX Stock Summary and Trading Ideas (Co-Diagnostics | NASDAQ:CODX)

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

What symbol and exchange does Co-Diagnostics shares trade?

Co-Diagnostics trades on the NASDAQ stock market under the symbol CODX.

What is Co-Diagnostics stock price doing today?

As of April 2, 2026, CODX stock price declined to $1.54 with 91,761 million shares trading.

How much is Co-Diagnostics worth?

CODX has a market cap of $3.23 million. This is considered a Sub-Micro Cap stock.

How much money does Co-Diagnostics make?

Last quarter Co-Diagnostics reported $263,922 in Revenue and -$16.65 earnings per share. This beat revenue expectation by $113,922 and missed earnings estimates by -$12.75.

What are the support and resistance levels for Co-Diagnostics (CODX)?

CODX support price is $1.39 and resistance is $1.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CODX shares will trade within this expected range on the day.